[Study of a patient with azoospermia due to variant of MOV10L1 gene].

چکیده اصلی

OBJECTIVE: To explore the clinical and genotypic characteristics of a patient with Sertoli cell-only syndrome (SCOS) due to variants of MOV10L1 gene. METHODS: A 27-year-old patient with Non-obstructive azoospermia (NOA) underwent routine semen analysis. Serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), progesterone (P), estradiol (E2), prolactin (PRL), and testosterone (T) were determined by chemiluminescence assays. Peripheral blood samples were collected for G-banded karyotyping analysis. Multiplex PCR fluorescence detection was used to screen for AZF gene microdeletions. Whole exome sequencing (WES) and Sanger sequencing were performed simultaneously. Testicular biopsy tissues were subjected to Hematoxylin-Eosin (HE) staining to assess seminiferous tubule cell composition, and MOV10L1 protein expression was detected by immunohistochemical staining. Bioinformatics tools were employed to predict the pathogenicity of variants and their impact on protein structure and function. This study was approved by the Medical Ethics Committee of the Guangdong Institute of Reproductive Sciences [Ethics No.: 2023(01)]. RESULTS: The patient's two semen analyses had failed to detect any sperm. Hormone tests indicated elevated FSH (22.32 mIU/mL) and PRL (397.6 mIU/mL), while T (3.68 nmol/L) and E2 (38.32 pmol/L) were reduced. Chromosomal karyotyping revealed 46,XY, and no AZF gene deletion was detected. WES and Sanger sequencing detected compound heterozygous variants of the MOV10L1 gene, including a c.345C>A (p.C115X) nonsense variant and a c.3323C>T (p.T1108I) missense variant, with the former being unreported previously. HE staining showed only Sertoli cells in the seminiferous tubules, confirming the diagnosis of SCOS. Immunohistochemical staining revealed absent MOV10L1 protein expression in the testicular tissue. Based on the guidelines from American College of Medical Genetics and Genomics (ACMG), the c.345C>A (p.C115X) was classified as a pathogenic variant (PVS1+PM2_Supporting+PP4), while the c.3323C>T (p.T1108I) was deemed variant of uncertain significance (PM2_Supporting+PP3_Supporting+PP4). Bioinformatics analysis demonstrated that c.345C>A (p.C115X) may cause premature termination of protein translation, while c.3323C>T (p.T1108I) may disrupt the hydrophobicity of the RNA helicase domain, reducing the active pocket volume and decreasing its affinity for MILI protein. CONCLUSION: This study has diagnosed a case of SCOS due to compound heterozygous variants of the MOV10L1 gene, which also enriched its mutational spectrum.

ترجمه فارسی چکیده

هدف این مطالعه بررسی ویژگی‌های بالینی و ژنوتیپی بیماری با سندرم سلول‌های سروتی (SCOS) ناشی از جهش‌های ژن MOV10L1 بود. در این مطالعه، یک بیمار ۲۷ ساله با آزواسپرمی بدون انسداد (NOA) مورد بررسی قرار گرفت. آزمایش‌های هورمونی، آنالیز کروموزومی، غربالگری جهش‌های میکروحذفی AZF، توالی‌یابی تمام اگزون (WES) و توالی‌یابی Sanger انجام شد. بافت بیوپسی بیضه با رنگ‌آمیزی هماتوکسیلین-ایوزین بررسی شد و بیان پروتئین MOV10L1 با روش ایمونوهیستوشیمی سنجیده شد. بر اساس دستورالعمل‌های کالج پزشکی ژنتیک آمریکا (ACMG)، جهش c.345C>A (p.C115X) به عنوان جهش خطرناک و جهش c.3323C>T (p.T1108I) به عنوان جهش با اهمیت بالینی نامشخص طبقه‌بندی شدند.

متن کامل اصلی